Table 5.
Gene Expression Level Change and Treatment Response
Response Group | Change in CTC Levels from Baseline to Week 8 | ||||
---|---|---|---|---|---|
Mean | Median | Range | Quartiles | p-value | |
| |||||
CK19 | |||||
Yes (N=21) | − 350 | 0 | −4063 - 865 | 25%: −1 75%: −204 |
0.25 |
No (N=38) | −75 | −2 | −16,272-11,906 | 25%: 2 75%: −13 |
|
| |||||
Mammoglobin | |||||
Yes (N=21) | − 67 | 0 | −738 - 36.0 | 25%: 0 75%: −11 |
0.05 |
No (N=38) | − 32 | 0 | −970 - 313 | 25%: 7 75%: − 0.1 |
|
| |||||
Response Group | Change in CTC Levels from Baseline to End of Treatment | ||||
Mean | Median | Range | Quartiles | p-value | |
| |||||
CK19 | |||||
Yes (N=13) | 2732 | 0 | −3392 - 39,385 | 25%: 2 75% −141 |
0.34 |
No (N=31) | − 479 | 0 | −15,332 - 999 | 25%: 10 75%: − 8 |
|
| |||||
Mammoglobin | |||||
Yes (N=13) | 1176 | 0 | −192 -15,506 | 25%: 0 75%: −0.6 |
0.09 |
No (N=31) | −0.06 | 0 | −970 -1459 | 25%: 9 75% −0.1 |